Bibliography
  1. Bioterrorism Alleging Use of Anthrax and Interim Guidelines for Management. (1999).
    Morbidity and Mortality Weekly Report, 48(04), 69-74. Retrieved February 12, 2004, from http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/00056353.htm.
  2. Recognition of Illness Associated with the Intentional Release of a Biologic Agent. (2002).
    The Journal of the American Medical Association. 286(17). Retrieved February 12, 2004,
    from http://jama.ama-assn.org/cgi/content/full/286/17/2088.
  3. Bailey, Thomas A., and David M. Kennedy. (1987). The American Pageant. 8th ed. New York: D.C. Heath and Company.
  4. Biological Diseases / Agents Listing. Centers for Disease Control and Prevention. Retrieved March 11, 2002, from http://www.bt.cdc.gov/Agent/Agentlist.asp.
  5. Center for Disease Control and Prevention. Public Health Emergency Preparedness & Response. (2001, October). Interim Recommendations for the Selection and Use of Protective Clothing and Respirators Against Biological Agents. Retrieved February 12, 2004 from http://www.bt.cdc.gov/DocumentsApp/Anthrax/Protective/10242001Protect.asp.
  6. Delaney, Kathleen A. MD. (2002). Impact of the threat of biological and chemical terrorism on public safety-net hospitals. The International Lawyer 36(1), 21-28.
  7. Henderson, Donald A. (July-September 1998) Bioterrorism as a public health threat. Emerging Infectious Diseases. 4(3). Retrieved February 12, 2004 from http://www.cdc.gov/ncidod/EID/vol4no3/hendrsn.htm.
  8. Henderson, Donald A. and Bernard Moss. (1999) Smallpox and Vaccinia. Vaccines, 3rd ed. Electronic Book. Retrieved February 12, 2004 from http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=vacc.chapter.3.
  9. Henderson, Donald A. MD; Thomas V. Inglesby, MD; John G. Bartlett, MD; Michael S. Ascher, MD; Edward Eitzen, MD, MPH; Peter B. Jahrling, PhD; Jerome Hauer, MPH; Marcelle Layton, MD; Joseph McDade, PhD; Michael T. Osterholm, PhD, MPH; Tara O’Toole, MD, MPH; Gerald Parker, PhD, DVM; Trish Perl, MD, MSc; Phillip K. Russell, MD; Kevin Tonat, PhD; for the Working Group on Civilian Biodefense. (1999) Smallpox as a biological weapon. The Journal of American Medical Association. 281(22), 2127-2137. Retrieved February 12, 2004 from http://jama.ama-assn.org/cgi/reprint/281/22/2127.pdf.
  10. Kaufmann, Arnold F., Martin I. Meltzer, and George P. Schmid. (April-June 1997) The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justified? Emerging Infectious Diseases. 3(2). Retrieved February 12, 2004 from http://www.cdc.gov/ncidod/eid/vol3no2/kaufman.htm.
  11. McDade, Joseph E., and David Franz. (1998, July – September) Bioterrorism as a Public Health Threat. Emerging Infectious Diseases. 4(3). Retrieved February 12, 2004 from http://www.cdc.gov/ncidod/eid/vol4no3/mcdade.htm.
  12. Miller, J., Engelberg, S. & Broad, W. (2002). Biological weapons and America’s secret war: Germs. New York: Touchstone.
  13. Mitchell, Steve. (2002, June 21). CDC Advised to Change Smallpox Plan. United Press International.
  14. Munford, Robert. (April 2002). Recognizing Smallpox. University of Texas Southwestern Website.
  15. Preston, Richard. The Demon in the Freezer. New York, Random House Inc., 2002.
  16. Russell, Philip K. “Biologic Terrorism – Responding to the Threat.” Emerging Infectious Diseases 3.2 (April-June 1997): 203-204.
  17. Rotz, Lisa D., Ali S. Khan, Scott R. Lillibridge, Stephen M. Ostroff, and James M. Hughes. “Public Health Assessment of Potential Biological Terrorism Agents.” Emerging Infectious Diseases 8.2 (2002): Feb. 2002. Retrieved March 15, 2004, from http://www.cdc.gov/ncidod/EID/vol8no2/01-0164.htm.
  18. Simons, Lewis M. “Weapons of Mass Destruction: An ominous new chapter opens on the twentieth century’s ugliest legacy.” National Geographic November (2002): 2-35.
  19. Smallpox: What Every Clinician Should Know. Webcast. 13 December 2001. Carolina School of Public Health—On Demand Webcasts. Retrieved March 15, 2004, from
    http://www.sph.unc.edu/about/webcasts/2001-12-13_smallpox/transcripts_archive.htm.
  20. UT Southwestern Medical Center faculty. “Bioterrorism: Summary of Issues and Recommendations.” The Southwestern Medical Foundation. University of Texas Southwestern, Dallas. 23 October 2001. Retrieved August 8, 2003, from http://www.swmed.edu/home_pages/news/handout.htm.
  21. Wilde, Henry MD, Reviewer. (1998). “Medical Aspects of Chemical and Biological Warfare.” The Journal of the American Medical Association, 280, 1199. Retrieved October 8, 2003, from http://jama.ama-assn.org/cgi/reprint/280/13/1199.
  22. Centers for Disease Control and Prevention. (2003). Course: Smallpox: Disease, Provention and Intervention. Waldorf, MD: PHF Publication Sales. Retrieved January 21, 2004, from http://www.bt.cdc.gov/agent/smallpox/training/overview/index.asp
    Top of Page